<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since tenascin C is a factor expressed highly in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated matrix, it would be a desirable first step for targeting the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific microenvironment </plain></SENT>
<SENT sid="1" pm="."><plain>In fact, a high level of tenascin C expression has been reported in most <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, including <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, the targeted binding of tenascin C in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stroma would inhibit <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> by modulating <z:e sem="disease" ids="C1516170" disease_type="Neoplastic Process" abbrv="">cancer cell growth</z:e> and migration </plain></SENT>
<SENT sid="3" pm="."><plain>We isolated a <z:chebi fb="7" ids="16670">peptide</z:chebi> that bound to tenascin C by phage display <z:chebi fb="7" ids="16670">peptide</z:chebi> library selection, and the selected <z:chebi fb="7" ids="16670">peptide</z:chebi> specifically recognized tenascin C protein in xenograft mouse tissue </plain></SENT>
<SENT sid="4" pm="."><plain>We also observed exclusive staining of tenascin C by the selected <z:chebi fb="7" ids="16670">peptide</z:chebi> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> patient tissues </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, the <z:chebi fb="7" ids="16670">peptide</z:chebi> reduced tenascin C-induced cell rounding and migration </plain></SENT>
<SENT sid="6" pm="."><plain>We propose that the tenascin C targeting <z:chebi fb="7" ids="16670">peptide</z:chebi> may be useful as a specific anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnostic and therapeutic tool for most human <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
</text></document>